Safety and efficacy of insulin aspart versus insulin lispro in insulin pumps in children and adolescents with type 1 diabetes

Trial Profile

Safety and efficacy of insulin aspart versus insulin lispro in insulin pumps in children and adolescents with type 1 diabetes

Completed
Phase of Trial: Phase III

Latest Information Update: 24 Dec 2016

At a glance

  • Drugs Insulin aspart; Insulin lispro
  • Indications Type 1 diabetes mellitus
  • Focus Registrational; Therapeutic Use
  • Sponsors Novo Nordisk
  • Most Recent Events

    • 07 Jun 2017 Biomarkers information updated
    • 20 May 2009 Actual end date (May 2006) added as reported by ClinicalTrials.gov.
    • 01 Feb 2008 Efficacy and tolerability results have been published.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top